{
    "organizations": [],
    "uuid": "fea1cfa7e3fc8fca03f6e80adab449e12a46e6c9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-nanjing-pharmaceutical-gets-approv/brief-nanjing-pharmaceutical-gets-approval-to-issue-4-0-billion-yuan-commercial-paper-idUSH9N1RQ009",
    "ord_in_thread": 0,
    "title": "BRIEF-Nanjing Pharmaceutical Gets Approval To Issue 4.0 Billion Yuan Commercial Paper",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - NanJing Pharmaceutical Co Ltd :\n* SAYS IT GETS APPROVAL TO ISSUE 4.0 BILLION YUAN ($636.55 million) COMMERCIAL PAPER Source text in Chinese: bit.ly/2qCniiG Further company coverage: ($1 = 6.2839 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-16T15:51:00.000+03:00",
    "crawled": "2018-04-17T12:16:50.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "nanjing",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "get",
        "approval",
        "issue",
        "billion",
        "yuan",
        "million",
        "commercial",
        "paper",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}